Efficacy and Safety of Vandetanib (ZD6474) in Patients With Metastatic Papillary or Follicular Thyroid Cancer
Clinical trial NCT00537095 · COMPLETED
Trial details
- NCT number
- NCT00537095
- Sponsor
- Genzyme, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-09-28
- Primary completion
- 2009-12-02
- Enrollment
- 164
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.